Concepedia

Jason Lamar

JL

12

Publications

351

Citations

12

H-Index

2003

Active since

Affiliations

Eli Lilly (United States)(Current)

Jason Lamar is an author at Eli Lilly (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2003–2016

12

Publications

12

Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor

Yvonne Y. Yip, Frantz Victor, Jason Lamar et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 65 citations · Full text

, , +9

P4 and P1′ optimization of bicycloproline P2 bearing tetrapeptidyl α-ketoamides as HCV protease inhibitors

Yvonne Y. Yip, Frantz Victor, Jason Lamar et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 41 citations · Full text

, , +9

Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR

Jason Lamar, Jingdan Hu, Ana B. Bueno et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 33 citations · Full text

, , +8

P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors

Frantz Victor, Jason Lamar, Nancy Snyder et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 32 citations · Full text

, , +11

Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase

Michaël Génin, Isabel C. Gonzalez Valcarcel, William G. Holloway et al. · Journal of Medicinal Chemistry · 2016 · 31 citations · Full text

, , +23

Rows per page

1–5 of 12